Su, C., H. Chai, Y. See, and R. S. Kumar. “GLYCEMIC CONTROL AND BODY WEIGHT EFFECTS OF SGLT2 INHIBITORS (EMPAGLIFLOZIN 25 MG, EMPAGLIFLOZIN 12.5 MG AND DAPAGLIFLOZIN 10 MG) IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS: A SINGLE CENTRE STUDY”. Journal of the ASEAN Federation of Endocrine Societies, vol. 39, no. S1, July 2024, p. 25, https://asean-endocrinejournal.org/index.php/JAFES/article/view/4457.